Use of idebenone and analogues against ଲ amyloid induced cytotoxicity
Patent 6271266 Issued on August 7, 2001. Estimated Expiration Date: 
November 9, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 9, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesNerve growth factor secretion inducing composition Patent #: 5059627 InventorsAssigneeApplicationNo. 180463 filed on 11/09/1998US Classes:514/678Benzene ring containingExaminersPrimary: Jones, Dwayne C.Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/185Foreign Application Priority Data1996-07-11 JPAbstractA compound of the formula: ##STR1##wherein R1 represents a lower alkyl; R2 represents H, an optionally substituted alkyl or an optionally substituted alkenyl; R3 and R4 each represents an optionally substituted lower alkyl or a lower alkoxy, or R3 and R4 form, taken together, an optionally substituted butadienylene; and X1 and X2 each represents an optionally esterified or etherified hydroxy, or a salt thereof is useful for protecting cells from the cytotoxicity of ଲ-amyloid protein.Other References
| |
